abstract |
Plasma concentrations and exposures for improved in-poisoning modes compared to direct administration of the indoxic mode in patients requiring immunosuppressive therapy mediated by the indoleamine-2,3-dioxygenase pathway, such as those with cancer or chronic infectious disease Lt; RTI ID = 0.0 > pharmaceutically < / RTI > |